Young coconut juice significantly reduces histopathological changes in the brain that is induced by hormonal imbalance: A possible implication to postmenopausal women

Histology and Histopathology

Volumn 24, Issue 6, 2009, Pages 667-674

  Radenahmad, Nisaudah ^a   Saleh, Farid ^b   Sawangjaroen, Kitja ^a   Rundorn, Wilart ^a   Withyachumnarnkul, Boornsirm ^c   Connor, James R ^d  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b KUWAIT UNIVERSITY   (Kuwait)

^c Mahidol University   (Thailand)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Estrogen; Menopause; Neurofilaments; Neuron cell death; Overiectomy; Parvalbumin; Young coconut juice

Indexed keywords

RATTUS;

ESTRADIOL; NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN H; PARVALBUMIN; PHYTOESTROGEN; PLANT EXTRACT;

ANIMAL; ARTICLE; BLOOD; BRAIN; CELL DEATH; CHEMISTRY; COCONUT; DISEASE MODEL; DRUG EFFECT; FEMALE; FRUIT; HUMAN; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; METABOLISM; NERVE CELL; OVARIECTOMY; PHYTOTHERAPY; POSTMENOPAUSE; RAT; WISTAR RAT;

ANIMALS; BRAIN; CELL DEATH; COCOS; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; FRUIT; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; NEUROFILAMENT PROTEINS; NEURONS; OVARIECTOMY; PARVALBUMINS; PHYTOESTROGENS; PHYTOTHERAPY; PLANT EXTRACTS; POSTMENOPAUSE; RATS; RATS, WISTAR;

EID: 67650246234     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S. and Itoh N. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinase. J. Biol. Chem. 262, 5592-5595.
2. Celio M. (1986) Parvalbumin in most gamma-aminobutyric acidcontaining neurons of the rat cerebral cortex. Science 231, 995-997.
3. Choi J., Romeo R.D., Brake W.G, Bethea C.L., Rosenwaks Z. and McEwen B.S. (2003). Estradiol increases pre-and post-synaptic proteins in the CA1 region of the hippocampus in female rhesus macaques (Macaca mulatta). Endocrinology 144, 4734-4738.
4. DeFelipe J. (1997). Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J. Chem. Neuroanat. 14, 1-19.
5. Dubal D.B., Rau S.W., Shughrue P.J., Zhu H., Yu J., Cashion A.B., Suzuki S., Gerhold L.M., Bottner M.B., Dubal S.B., Merchanthaler I., Kindy M.S. and Wise P.M. (2006). Differential modulation of estrogen receptors (ERs) in ischemic brain injury: A role for ERa in estradiol-mediated protection against delayed cell death. Endocrinology 147, 3076-3084.
6. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I., Kindy M.S. and Wise P.M. (2001). Estrogen receptor a, not ß, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. USA 98, 1952-1957.
7. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I. and Wise P.M. (1999). Estradiol modulates bcl-2 in cerebral ischemia: A potential role for estrogen receptors. J. Neurosci. 19, 6385-6393.
8. Feller S.M. and Wong T.W. (1992) Identification and characterization of a cytosolic protein tyrosine kinase of Hela cells. Biochemistry 31, 3044-3051.
9. Foster T.C., Sharrow K.M., Kumar A. and Masse J. (2003). Interaction of age and chronic estradiol replacement on memory and markers of brain aging. Neurobiol. Aging 24, 839-852.
10. Gould E., Woolley C.S., Frankfurt M. and McEwen B.S. (1990) Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adult hood. J. Neurosci. 10, 1286-1291.
11. Green P.S., Perez E.J., Calloway T. and Simpkins J.W. (2000). Estradiol attenuation of beta-amyloid-induced toxicity: a comparison. J. Neurocytol. 29, 419-423.
12. Greene J.R.T., Radenahmad N., Wilcock G.K., Neal J.W. and Pearson R.C.A. (2001) Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzeimer's disease. Neuropathol. Appl. Neurobiol. 27, 339-342.
13. Havsteen B.H. (2002). The biochemistry and medical significance of the flavonoids. Pharmacol. Therap. 96, 67-202.
14. 2+-binding proteins in human neurodegenerative disorders. Trends Neurosci. 15, 259-264.
15. Hof P.R., Cox K. and Morrison J.H. (1990). Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J. Comp. Neurol. 301, 44-54.
16. Hof P.R., Nimchinsky E.A. and Morrison J.H. (1995). Neurochemical phenotype of corticocortical connections in the macque monkey: quantitative analysis of a subset of neurofilament proteinimmunoreactive projection neurons in frontal, parietal, temporal, and cingulated cortices. J. Comp. Neurol. 362, 109-133.
17. Hwang K., Lee Y., Yoo K., Kang T., Lim S.S. and Kim S.M. (2006). Soybean isoflavones alter parvalbumin in hippocampus of mid-aged normal female, ovariectomized female, and normal male rats. Acta Pharmacol. Sin. 27, 59-65.
18. Igbal M.J., Dalton M. and Sawers R.S. (1983). Binding of testosterone and oestradiol to sex hormone binding globulin, human serum albumin and other plasma proteins: evidence for non-specific binding of oestradiol to sex hormone binding globulin. Clin. Sci. 64, 307-314.
19. Iuvone L., Geloso M.X. and Dell'Anna E. (1996). Changes in open filed behavior, spatial memory, and hippocampal parvalbumin immunoreactivity following enrichment in rats exposed to neonatal anoxia. Exp. Neurol. 139, 25-33.
20. Kawaguchi Y., Katsumaru H., Kosaka T., Heizman C.W. and Hama K. (1987). Fast spiking cells in rat hippocampus (CA1 region) contain the calcium-binding protein parvalbumin. Brain Res. 416, 369-374.
21. 2+-binding protein parvalbumin in the rat hippocampus and dentate gyrus. Brain Res. 419, 119-130.
22. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H. and van der Saag. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-63.
23. Law A.J. and Harrison P.J. (2003). The distribution and morphology of prefrontal cortex pyramidal neurons identified using antineurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression. J. Psychiat. Res. 37, 487-499.
24. Lichtenberg V., Schulte-Baukloh A., Lindner C.H. and Braendle W. (1992). Discrepancies between results of serum 17p-Oestradiol E2 determinations carried out using different immunoassay kits in women receiving oestrogen replacement therapy. Lab. Med. 16, 412-416.
25. Liu S.J., Fang Z.Y., Yang Y., Deng H.M. and Wang J.Z. (2003) Alzheimer-like phosphorylation of tau and neurofilament induced by cocaine in vivo. Acta Pharmacol. Sin. 24, 512-518.
26. McEwen B.S. (1996). Gonadal and adrenal steroids regualte neurochemical and structural plasticity of the hippocampus via cellular mechanisms involving NMDA receptors. Cell. Mol. Neurobiol. 16, 103-116.
27. McEwen B.S. and Alves S.E. (1999). Estrogen actions in the central nervous system. Endocrine Rev. 20, 279-307.
28. McEwen B.S., Tanapat P. and Weiland N.G. (1999). Inhibition of dendritic spine induction on hippocampal CA1 pyramidal neurons by a nonsteiroidal estrogen antagonist in female rats. Endocrinology 140, 1044-10447.
29. Merchenthaler I. and Shughrue P.J. (2005). Neuroprotection by estrogen in animal models of ischemia and Parkinson's disease. Drug Dev. Res. 66, 172-181.
30. Moghadasian M.H. (2000). Pharmacological properties of plant sterols. In vivo and in vitro observations. Life Sci. 67, 605-615.
31. Morrison J.H., Lewis D.A., Campbell M.J., Huntley G.W., Benson D.L. and Bouras C. (1987). A monoclonal antibody to nonphosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease. Brain Res. 416, 331-336.
32. Paxinos G. and Watson C. (1986). The rat brain in stereotaxic coordinates. 2nd ed. Paxinos G. and Watson C. (eds). Academic Press, Inc. San Diego. pp 38-89.
33. Petanceska S.S., Nagy V., Frail D. and Gandy S. (2000). Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Exp. Gerontol. 54, 2212-2217.
34. Peterson G. (1995). Evaluation of the biochemical targets of geistein in tumor cells. J. Nutr. 125, 784s-9s.
35. Punghmatharith B. (1988). Sex hormone-like substances in young coconut juice and their effects on uterine growth in rats. Songklanagarind J. Sci. Technol. 10, 221-226.
36. Radenahmad N. (2000). An immunohistochemical study of the neocortex in Alzheimer's disease. Doctoral dissertation, University of Sheffield, 2000.
37. Radenahmad N., Neal J.W., Wilcock G. and Pearson R.C.A. (2003). A Neurofilament antibody recognizes a subset of pyramidal cells in the human neocortex that are preserved in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 29, 312-320.
38. Radenahmad N., Vongvatcharanon U., Withyachumnarnkul B. and Connor R.J. (2006). Serum levels of 17ß-estradiol in ovariectomized rats fed young-coconut juice and its effect on wound healing. Songklanagarind J. Sci. Technol. 28, 897-910.
39. Rajadhyaksha A., Leveque J., Macias W., Barczak A. and Konradi C. (1998). Molecular components of striatal plasticity: the various routes of cyclic AMP pathways. Dev. Neurosci. 20, 204-215.
40. Shughrue P.J. and Merchenthaler I. (2000). Estrogen is more than just a 'sex hormone': Novel sites for estrogen action in the hippocampus and cerebral cortex. Frontr. Neuroendocrinol. 21, 95-101.
41. Spilkova J. and Hubik J. (1992). The biological actions of flavonoids. II. Pharm. Unserer. Zeit. 21, 174-182.
42. Stahl S., Chun T.Y. and Gray W.G. (1998). Phytoestrogen act as estrogen agonists in an estrogen-responsive pituitary cell line. Toxicol. Appl. Pharmacol. 152, 41-48.
43. Sternberger L.A. and Sternberger N. (1983). Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. USA 80, 6126-6130.
44. Tietz N.W. (1995). The CIA Technique. In: Clinical guide to laboratory tests. 3rd ed. Tietz N.W. (ed). Saunders Co. Philadelphia. pp 216.
45. Vickers J.C., Riederer B.M., Marugg R.A., Buee-Scherrer V., Buee L. and Delacourte A. (1994). Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience 62, 1-13.
46. Weaver C.E. Jr, Park-Chung M., Gibbs T.T. and Farb D.H. (1997). 17beta-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 761, 338-341.
47. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Bottner M. and Rosewell K.L. (2001). Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res. Rev. 37, 313-319.
48. Woolley C.S. (1998). Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus. Horm. Behav. 34, 140-148.
49. Woolley C.S. and McEwen B.S. (1993). Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol. 336, 293-306.